Cellectar Biosciences, Inc.
CLRB
$0.2515
$0.00732.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.03% | 32.45% | -35.38% | 318.52% | -49.62% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -41.21% | -19.68% | 52.30% | 50.55% | -20.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -32.45% | 28.65% | -32.54% | 295.75% | -48.02% |
|
|
|||||
| Total Current Assets | -32.45% | 28.65% | -32.54% | 295.75% | -48.02% |
| Net Property, Plant & Equipment | -12.48% | -5.88% | -4.03% | -5.17% | 12.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -31.69% | 26.91% | -31.52% | 255.33% | -43.97% |
|
|
|||||
| Total Accounts Payable | -50.56% | 28.49% | -12.59% | -19.44% | 17.45% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.46% | 4.53% | 4.46% | 25.42% | 4.80% |
| Total Finance Division Other Current Liabilities | -85.60% | 38.27% | -59.08% | 30.78% | 87.45% |
| Total Other Current Liabilities | -85.60% | 38.27% | -59.08% | 30.78% | 87.45% |
| Total Current Liabilities | -53.79% | 33.93% | -46.87% | 12.59% | 53.96% |
|
|
|||||
| Total Current Liabilities | -53.79% | 33.93% | -46.87% | 12.59% | 53.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.16% | -4.76% | -4.39% | -3.99% | -3.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -52.78% | 32.80% | -46.18% | 12.27% | 52.22% |
|
|
|||||
| Common Stock & APIC | 5.91% | 4.97% | 4.46% | 22.91% | -6.34% |
| Retained Earnings | -0.96% | -6.37% | -0.40% | -13.14% | 3.46% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 788.98% | -65.85% | 199.36% | 76.98% | -34.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -87.31% | 62.57% | -50.00% | 204.47% | -68.61% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -87.31% | 62.57% | -50.00% | 204.47% | -68.61% |
|
|
|||||
| Total Common Equity | 788.98% | -65.85% | 199.36% | 76.98% | -34.62% |
| Total Preferred Equity | -87.31% | 62.57% | -50.00% | 204.47% | -68.61% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.26% | 20.23% | -0.87% | 200.77% | -401.65% |
|
|
|||||